Many nations have stopped recommending the vaccine for children, FDA commissioner said. Critics say vaccinating pregnant ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine with age restrictions after a six-week delay. The brand name is Nuvaxovid. Photo courtesy Novavax May 18 (UPI ...

The Food and Drug Administration has granted full approval to Novavax, Inc. (NASDAQ:NVAX) COVID-19 vaccine, but with notable ...

See what infectious disease doctors have to say as government officials appear poised to scale back COVID vaccines and the ...

The U.S. FDA has approved Novavax's COVID-19 vaccine, Nuvaxovid, for older adults and those aged 12 to 64 at risk of severe illness. Despite missed deadlines and regulatory challenges, the approval is ...

Almost immediately after former US president Joe Biden's office announced he had been diagnosed with an aggressive prostate ...